目的:探讨斑块状银屑病患者表皮p16^INK4a基因启动子甲基化状态,并分析与其临床资料的相关性。方法:按银屑病皮损面积和严重度指数(PASI)评分评估患者病情严重程度。采用甲基化特异PCR(MAP)方法检测p16^INK4a甲基化状态。结果:①银屑病患者皮损和非皮损表皮p16^INK4a基因的甲基化率分别为32.14%(9/28)和7.14%(2/28),皮损处明显高于非皮损处(P〈0.05),正常对照组中无表皮p16^INK4a基因甲基化(0/38);②进行期皮损表皮p16^INK4a基因的甲基化率明显高于稳定期皮损(P〈0.05);③皮损表皮p16^INK4a基因甲基化阳性患者的PASI评分明显高于甲基化阴性患者(P〈0.05)。结论:斑块状银屑病患者皮损表皮p16^INK4a基因启动子甲基化率明显增高,并与皮损严重程度和活动性有关,提示p16^INK4a基因启动子高甲基化在银屑病的发病中可能起作用。
Objective: To investigate the status of promoter methylation of p16^INK4a gene from plaque psoriatic epidermis and the correlation between methylation and clinical conditions. Methods: The severity of psoriasis was evaluated by PASI scores. The methylation of p16^INK4a gene was detected by methylation specific PCR (MSP). Results: The p16^INK4a methylation rate of psoriatic lesions was significantly higher than that of non-lesional skin. Methylation of p16^INK4a was not found in normal skins. The frequency of methylation of p16^INK4a was markedly increased in progressive phase compared with that in stationary phase. PASI score in methylation patients was higher than that in unmethylation patients. Conclusions: The promotor hypermethylation of p16^INK4a is observed significantly in the lesions from plaque psoriatic epidermis, and is related to the severity and of psoriasis. It suggests that the promotor hypermethylation of p16^INK4a may play a role in the development of psoriasis.